This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Biacna Topical Gel

Starting date:
June 27, 2013
Posting date:
July 17, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-34667

Recalled products

  1. Biacna Topical Gel

Reason

Out of specification results obtained for assay on a three month stability sample for lot 78843.

Depth of distribution

Samples directly distributed to doctors in Canada.

Affected products

A. Biacna Topical Gel

DIN, NPN, DIN-HIM
DIN 02359685
Dosage form

Gel

Strength
  • Clindamycin phosphate 1.2%
  • Tretinoin 0.025%
Lot or serial number
  • 78843
Companies
Recalling Firm
Valeant Canada LP
2150 St-Elzear Boulevard West,
Laval
H7L 4A8
Quebec
CANADA
Marketing Authorization Holder
Valeant Canada LP
2150 St-Elzear Boulevard West,
Laval
H7L 4A8
Quebec
CANADA

Date modified: